Summaries of the Section H (HML) update

Each month we issue a summary of the HML update. The table on this page gives a preview of the upcoming changes.

The table on this page gives a preview of the upcoming changes that will be announced in next month’s Section H of the Pharmaceutical Schedule.

The changes will be published in the Online HML(external link) around the 23^rd of this month and are effective from next month.

For any questions about these listing changes or the Pharmaceutical Schedule in general, email us at enquiry@pharmac.govt.nz.

18 March 2026 - preview of changes for April 2026

Pharmaceutical	Change
Amoxicillin cap 500 mg	Brand change Amoxycillin Sandoz – new listing and addition of PSS (p’code 2712601) Miro-Amoxicillin to be delisted 1 November 2026
Atezolizumab (Tecentriq) inj 60 mg per ml, 20 ml vial	amended restriction criteria
Bortezomib inj 3.5 mg vial	Brand change Bortezomib Eugia – new listing and addition of PSS (p’code 2723832) DBL Bortezomib to be delisted 1 September 2026
Brentuximab vedotin (Adcetris) inj 50 mg vial	amended restriction criteria
Candesartan cilexetil (Candesartan Viatris Sante) tab 4 mg, 8 mg, 16 mg and 32 mg	new listing Tab 4 mg (p’code 2725355) Tab 8 mg (p’code 2725363) Tab 16 mg (p’code 2725371) Tab 32 mg (p’code 2725398)
Dexamfetamine sulfate (Dexamfetamine Aspen) tab 5 mg	new listing (p’code 2642298)
Doxorubicin hydrochloride (Doxorubicin Ebewe) inj 2 mg per ml, 50 ml vial	to be delisted from 1 May 2026
Elexacaftor with tezacaftor, ivacaftor and ivacaftor (Trikafta)	new listing Oral granules elexacaftor 80 mg with tezacaftor 40 mg, ivacaftor 60 mg (28) and ivacaftor 59.5mg (28), sachets (p’code 2726246) Oral granules elexacaftor 100 mg with tezacaftor 50 mg, ivacaftor 75 mg (28) and ivacaftor 75 mg (28), sachets (p’code 2726238)
Elexacaftor with tezacaftor, ivacaftor and ivacaftor (Trikafta) Tab elexacaftor 50 mg with tezacaftor 25 mg, ivacaftor 37.5 mg (56) and ivacaftor 75 mg (28) Tab elexacaftor 100 mg with tezacaftor 50 mg, ivacaftor 75 mg (56) and ivacaftor 75 mg (28) Oral granules elexacaftor 80 mg with tezacaftor 40 mg, ivacaftor 60 mg (28) and ivacaftor 59.5mg (28), sachets Oral granules elexacaftor 100 mg with tezacaftor 50 mg, ivacaftor 75 mg (28) and ivacaftor 150 mg (28), sachets	amended restriction criteria
Epirubicin hydrochloride (Epirubicin Ebewe) inj 2 mg per ml, 5 ml vial and inj 2 mg per ml, 100 ml vial	to be delisted 1 May 2026
Ezetimibe with simvastatin (Zimybe) tab 10 mg with simvastatin 80 mg	new listing (p’code 2725622)
Fluconazole (Flucazole) cap 150 mg	new listing (p’code 2173824)
Gadobutrol inj 1 mmol per ml, 15 ml vial	delisted 1 April 2026
Gadobutrol (Gadovist 1.0) inj 604.72 mg per ml (equivalent to 1 mmol per ml), 5 ml, 7.5 ml and 10 ml prefilled syringe	new listing Inj 604.72 mg per ml (equivalent to 1 mmol per ml), 5 ml prefilled syringe (p’code 2724464) Inj 604.72 mg per ml (equivalent to 1 mmol per ml), 7.5ml prefilled syringe (p’code 2724456) Inj 604.72 mg per ml (equivalent to 1 mmol per ml), 10 ml prefilled syringe (p’code 2724448)
Gadobutrol (Gadovist 1.0) inj 604.72 mg per ml (equivalent to 1 mmol per ml), 15 ml vial	amended presentation description
Gadoxetate disodium (Primovist) inj 181.43 mg per ml (equivalent to 0.25 mmol per ml), 10 ml prefilled syringe	new listing (p’code 2724472)
Ipratropium bromide (Ipratropium Viatris) nebuliser soln 250 mcg per ml, 2 ml ampoule	new listing (p’code 2724863)
Ivacaftor (Kalydeco) oral granules 13.4 mg and 25 mg, sachet	new listing Oral granules 13.4 mg, sachet (p’code 2726254) Oral granules 25 mg, sachet (p’code 2726262)
Ivacaftor (Kalydeco) tab 150 mg and oral granules 13.4 mg, 25 mg, 50 mg and 75 mg, sachet	amended restriction criteria
Ketamine (Ketalar) inj 100 mg per ml, 2 ml vial	new listing (p’code 436895)
Lansoprazole (Lanzol Relief) cap 15 mg	new listing (p’code 2726017)
Lenalidomide (Lenalidomide Viatris) cap 15 mg	Pharmacode 2673541 to be delisted 1 August 2026
Letrozole (Accord) tab 2.5 mg	to be delisted 1 July 2026
Methadone hydrochloride (Methadone BNM) tab 5 mg	price decrease and addition of PSS
Naproxen (Noflam 250) tab 250 mg	new listing (p’code 2725495)
Oral feed (Ensure (Chocolate) and (Vanilla)) powder 15.9 g protein, 57.4 g carbohydrate and 14 g fat per 100 g, can, 800 g can	new pack size listing Ensure (Chocolate), 800 g (p’code 2720256) Ensure (Vanilla), 800 g (p’code 2720248)
Parecoxib (Parecoxib Juno) inj 40 mg vial	new listing (p’code 2547325)
Pegfilgrastim (Ziextenzo) inj 6 mg per 0.6 ml syringe	new Pharmacode listing (p’code 2724251)
Pegfilgrastim (Ziextenzo) inj 6 mg per 0.6 ml syringe	Pharmacode 2643340 to be delisted 1 October 2026
Pembrolizumab (Keytruda) inj 25 mg per ml, 4 ml vial	amended restriction criteria
Prednisolone hexanoate with cinchocaine hydrochloride (Scheriproct) suppos 1.3 mg with cinchocaine hydrochloride 1 mg per g	new listing (p’code 2725509)
Rosuvastatin (Rosuvastatin Sandoz) tab 10 mg and 40 mg	new listing tab 10 mg (p’code 2716720) tab 40 mg (p’code 2716747)
Thiamine hydrochloride (Thiamine Sterop) inj 50 mg per ml, 2 ml ampoule	new listing and addition of PSS (p’code 2722127)
Ticagrelor (Ticagrelor Mylan) tab 90 mg	new listing (p’code 2724820)
Valaciclovir (Valaciclovir Mylan and Valaciclovir Viatris) tab 1,000 mg	new listing Valaciclovir Mylan (p’code 2725991) Valaciclovir Viatris (p’code 2726009)
Vanzacaftor with tezacaftor and deutivacaftor (Alyftrek)	new listing Tab vanzacaftor 4 mg with tezacaftor 20 mg and deutivacaftor 50 mg (p’code 2726203) Tab vanzacaftor 10 mg with tezacaftor 50 mg and deutivacaftor 125 mg (p’code 2726211)
Zidovudine with lamivudine (Lamivudine/Zidovudine Viatris) tab 300 mg with lamivudine 150 mg	new listing (p’code 2724952)

Find previous months' summaries